Illustrative image – not actual.The Central government is likely to tweak its newly proposed Rs 10,000 crore scheme aimed at boosting domestic manufacturing of active pharmaceutical ingredients (APIs).
This will be done by widening its scope to also encourage exports of these raw materials for drug makers.
The scheme, which seeks to cut dependence on China for APIs, was meant to cater to only domestic demand.
However, in a recent meeting held by the government think tank Niti Aayog with the Ministry of Health and the Department of Pharmaceuticals, it was decided to expand the scope of the scheme to allow exports.
The new scheme seeks to reduce the dependency and ensure adequate domestic supply of bulk drugs and APIs.
This will be done by widening its scope to also encourage exports of these raw materials for drug makers.
The scheme, which seeks to cut dependence on China for APIs, was meant to cater to only domestic demand.
However, in a recent meeting held by the government think tank Niti Aayog with the Ministry of Health and the Department of Pharmaceuticals, it was decided to expand the scope of the scheme to allow exports.
The new scheme seeks to reduce the dependency and ensure adequate domestic supply of bulk drugs and APIs.
